AR044983A1 - Solidos con capa de difusion modulada - Google Patents
Solidos con capa de difusion moduladaInfo
- Publication number
- AR044983A1 AR044983A1 ARP040102322A ARP040102322A AR044983A1 AR 044983 A1 AR044983 A1 AR 044983A1 AR P040102322 A ARP040102322 A AR P040102322A AR P040102322 A ARP040102322 A AR P040102322A AR 044983 A1 AR044983 A1 AR 044983A1
- Authority
- AR
- Argentina
- Prior art keywords
- diffusion layer
- drug
- solid
- modulated
- modulated diffusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Sólidos con capa de difusión modulada que incluyen un excipiente y una sal soluble de un fármaco básico poco soluble; una sal soluble de un fármaco ácido poco soluble; o un fármaco no ionizable poco soluble, que son útiles, por ejemplo, para el suministro mejorado de fármacos. Reivindicación 1: Un sólido con capa de difusión modulada que comprende una sal soluble de un fármaco básico que presenta una solubilidad de al menos 50 microgramos/ml en un fluido acuoso a pH 6 a 7 a 25° C y un excipiente seleccionado entre el grupo que consiste de excipientes ácidos, excipientes solubilizantes, y combinaciones de los mismos; en los cuales por lo menos a un valor de pH, la tasa de disolución intrínseca del sólido con capa de difusión modulada es por lo menos 10 % mayor que la tasa de disolución intrínseca de la sal de fármaco sola al mismo pH, y en los cuales las tasas de disolución se determinan a 25° C en agua a un pH de 1 a 7 empleando el método del disco rotatorio. Reivindicación 8: Una composición que comprende: un sólido con capa de difusión modulada de acuerdo con cualquiera de las reivindicaciones 1 7; y un inhibidor del crecimiento de los cristales. Reivindicación 11: Un método para aumentar la biodisponibilidad de un fármaco que comprende proporcionar un sólido con capa de difusión modulada de acuerdo con cualquiera de las reivindicaciones 1 a 7. Reivindicación 12: Un método para preparar un sólido con capa de difusión modulada de acuerdo con cualquiera de la reivindicaciones 1, 4 y 7, el método que comprende preparar partículas que incluyen una sal soluble de un fármaco básico que presenta una solubilidad de al menos 50 microgramos/ml en un fluido acuoso a pH 6 a 7 a 25° C y un excipiente seleccionado entre el grupo que consiste de excipientes ácidos, excipientes solubilizantes y combinaciones de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48420503P | 2003-07-01 | 2003-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044983A1 true AR044983A1 (es) | 2005-10-12 |
Family
ID=34062033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102322A AR044983A1 (es) | 2003-07-01 | 2004-07-01 | Solidos con capa de difusion modulada |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050042291A1 (es) |
| EP (1) | EP1643948A1 (es) |
| JP (1) | JP2007527394A (es) |
| AR (1) | AR044983A1 (es) |
| BR (1) | BRPI0412190A (es) |
| CA (1) | CA2531116A1 (es) |
| MX (1) | MXPA06000178A (es) |
| TW (1) | TW200514576A (es) |
| WO (1) | WO2005004763A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100891887B1 (ko) | 2001-01-29 | 2009-04-03 | 시오노기세이야쿠가부시키가이샤 | 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서 함유하는의약 제제 |
| NZ591443A (en) * | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
| US8486452B2 (en) | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| EP2555757B1 (en) * | 2010-04-09 | 2016-05-25 | Bristol-Myers Squibb Holdings Ireland | Atazanavir sulfate formulations with improved ph effect |
| DE102011113749A1 (de) * | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole |
| US9447065B2 (en) | 2011-10-18 | 2016-09-20 | Raqualia Pharma Inc. | Pharmaceutical composition |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| WO2021096925A1 (en) * | 2019-11-12 | 2021-05-20 | W. L. Gore & Associates, Inc. | Drug coated balloon |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4028772A (en) * | 1971-04-02 | 1973-09-27 | Merck & Co., Inc | Chemical processes |
| US4355091A (en) * | 1980-08-25 | 1982-10-19 | Polaroid Corporation | Polymeric neutralizing layer with temporary crosslinks from an organo-metallic crosslinking agent |
| IT1255792B (it) * | 1992-08-05 | 1995-11-16 | Bayer Italia Spa | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda |
| US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
| CO4940492A1 (es) * | 1997-05-29 | 2000-07-24 | Merck & Co Inc | Inhibidor de proteasa de vih |
| DK1083885T3 (da) * | 1998-06-11 | 2007-02-26 | Pharmacia & Upjohn Co Llc | Delavirdintabletformulering |
| ES2251985T3 (es) * | 1999-03-24 | 2006-05-16 | R.P. Scherer Technologies, Inc. | Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion. |
| GEP20053427B (en) * | 1999-12-23 | 2005-01-25 | Pfizer Prod Inc | Pharmaceutical Compositions Providing Enhanced Drug Concentrations |
| WO2003000235A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
-
2004
- 2004-06-29 CA CA002531116A patent/CA2531116A1/en not_active Abandoned
- 2004-06-29 BR BRPI0412190-2A patent/BRPI0412190A/pt not_active IP Right Cessation
- 2004-06-29 MX MXPA06000178A patent/MXPA06000178A/es unknown
- 2004-06-29 JP JP2006518756A patent/JP2007527394A/ja not_active Abandoned
- 2004-06-29 EP EP04777364A patent/EP1643948A1/en not_active Withdrawn
- 2004-06-29 WO PCT/US2004/021143 patent/WO2005004763A1/en not_active Ceased
- 2004-06-29 US US10/881,712 patent/US20050042291A1/en not_active Abandoned
- 2004-07-01 AR ARP040102322A patent/AR044983A1/es not_active Application Discontinuation
- 2004-07-01 TW TW093119910A patent/TW200514576A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1643948A1 (en) | 2006-04-12 |
| US20050042291A1 (en) | 2005-02-24 |
| JP2007527394A (ja) | 2007-09-27 |
| MXPA06000178A (es) | 2006-04-11 |
| TW200514576A (en) | 2005-05-01 |
| BRPI0412190A (pt) | 2006-08-22 |
| WO2005004763A1 (en) | 2005-01-20 |
| CA2531116A1 (en) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055938A (es) | Formulaciones farmaceuticas liquidas de palonosetron | |
| CO6150131A2 (es) | Sistema de liberacion controlada y metodo para fabricarlo | |
| CO5560580A2 (es) | Formulaciones de sucralosa para disumular sabores desagradables | |
| CY1105771T1 (el) | Φαρμακευτικες συνθεσεις εφαρμογης στον βλεννογονο | |
| CL2010000816A1 (es) | Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06) | |
| WO2002053100A3 (en) | Pharmaceutical dosage form for oral administration of low molecular weight heparin | |
| ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
| AR068302A1 (es) | Peptidos para vacunas para canceres que expresan antigenos asociados con tumores | |
| UY27273A1 (es) | Solución oral de arilpiprazol | |
| AR038947A1 (es) | Suspension oral de sabor agradable y metodo | |
| ATE359779T1 (de) | Selbstemulgierende systeme zur abgabe von taxoiden | |
| WO2009066146A3 (en) | Stable solutions of sparingly soluble actives | |
| BG107347A (bg) | Висококонцентрирани стабилни разтвори на мелоксикам | |
| ES2720954T3 (es) | Formulaciones estabilizadas de estatina | |
| AR044983A1 (es) | Solidos con capa de difusion modulada | |
| AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
| CO6491061A2 (es) | Formulacion de omeprazol farmaceutica estable para administracion oral | |
| JP2011516509A (ja) | 水性医薬製剤 | |
| ES2531241T3 (es) | Composición farmacéutica líquida estable a base de trazodona | |
| NO20025277D0 (no) | Farmasöytisk administreringsform for peptider, dens fremstilling samt anvendelse | |
| AR041945A1 (es) | Sistema terapeutico multicapa de administracion a traves de las mucosas | |
| PE20070377A1 (es) | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol | |
| CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
| MXPA06007510A (es) | Composiciones de farmaco y formas de dosis novedosas de topiramato. | |
| AR047346A1 (es) | Composicion farmaceutica de vinflunina para administracion parnteral, proceso de preparacion y uso de la misma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |